(CVX) Chevron - Ratings and Ratios
Crude Oil, Natural Gas, Gasoline, Petrochemicals, Renewable Fuels
CVX EPS (Earnings per Share)
CVX Revenue
Description: CVX Chevron September 24, 2025
Chelsea Corporation (NYSE:CVX) is an integrated energy and chemicals company operating globally, organized into two primary segments: Upstream and Downstream.
The Upstream segment covers the full hydrocarbon value chain-from exploration, development, and production of crude oil and natural gas to the liquefaction, transport, and regasification of LNG, as well as pipeline transportation, gas processing, carbon capture and storage (CCS), and a gas-to-liquids (GTL) plant.
The Downstream segment focuses on refining crude oil into fuels and lubricants, marketing those products alongside crude oil and petrochemicals, producing renewable fuels, and moving both crude and refined products via pipelines, marine vessels, rail, and trucks. It also manufactures commodity petrochemicals, plastics, and fuel/lubricant additives.
Key operational metrics (2023) include ≈ 3.0 million barrels of oil equivalent per day (BOE/d) of total production, ≈ $10 billion of capital expenditures, and a dividend yield around 4.5 %. The segment mix remains roughly 55 % upstream and 45 % downstream, making Chevron relatively insulated from short-term refining spreads but still exposed to oil-price cycles. Macro drivers such as global LNG demand growth, tightening ESG regulations, and the ongoing transition to low-carbon fuels are central to its long-term outlook.
If you’re looking to deepen the quantitative analysis of CVX’s valuation and risk profile, a quick look at ValueRay’s data dashboards can provide the granular financial models and scenario tools you need.
CVX Stock Overview
| Market Cap in USD | 309,316m |
| Sub-Industry | Integrated Oil & Gas |
| IPO / Inception | 2001-10-19 |
CVX Stock Ratings
| Growth Rating | 16.4% |
| Fundamental | 48.5% |
| Dividend Rating | 70.4% |
| Return 12m vs S&P 500 | -11.7% |
| Analyst Rating | 3.88 of 5 |
CVX Dividends
| Dividend Yield 12m | 4.42% |
| Yield on Cost 5y | 10.57% |
| Annual Growth 5y | 6.02% |
| Payout Consistency | 84.4% |
| Payout Ratio | 112.5% |
CVX Growth Ratios
| Growth Correlation 3m | -30.3% |
| Growth Correlation 12m | 24.1% |
| Growth Correlation 5y | 66.5% |
| CAGR 5y | -2.07% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.09 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.17 |
| Sharpe Ratio 12m | 1.14 |
| Alpha | -9.59 |
| Beta | 0.813 |
| Volatility | 22.00% |
| Current Volume | 9835.9k |
| Average Volume 20d | 6419.4k |
| Stop Loss | 150.3 (-3%) |
| Signal | 0.28 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (12.85b TTM) > 0 and > 6% of Revenue (6% = 11.31b TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -4.13pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1.58% (prev 1.27%; Δ 0.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 22.47b > Net Income 12.85b (YES >=105%, WARN >=100%) |
| Net Debt (33.82b) to EBITDA (41.71b) ratio: 0.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.08 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.81b) change vs 12m ago 0.05% (target <= -2.0% for YES) |
| Gross Margin 26.86% (prev 29.85%; Δ -3.00pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 64.36% (prev 74.84%; Δ -10.48pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 21.12 (EBITDA TTM 41.71b / Interest Expense TTM 1.05b) >= 6 (WARN >= 3) |
Altman Z'' 4.20
| (A) 0.01 = (Total Current Assets 41.54b - Total Current Liabilities 38.56b) / Total Assets 326.50b |
| (B) 0.63 = Retained Earnings (Balance) 205.85b / Total Assets 326.50b |
| (C) 0.08 = EBIT TTM 22.28b / Avg Total Assets 292.87b |
| (D) 1.50 = Book Value of Equity 204.68b / Total Liabilities 136.66b |
| Total Rating: 4.20 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 48.48
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 3.39% = 1.70 |
| 3. FCF Margin 5.57% = 1.39 |
| 4. Debt/Equity 0.22 = 2.48 |
| 5. Debt/Ebitda 0.81 = 2.01 |
| 6. ROIC - WACC (= 0.39)% = 0.48 |
| 7. RoE 8.06% = 0.67 |
| 8. Rev. Trend -59.98% = -4.50 |
| 9. EPS Trend -94.92% = -4.75 |
What is the price of CVX shares?
Over the past week, the price has changed by -0.38%, over one month by -0.70%, over three months by +1.22% and over the past year by +1.37%.
Is Chevron a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CVX is around 143.16 USD . This means that CVX is currently overvalued and has a potential downside of -7.65%.
Is CVX a buy, sell or hold?
- Strong Buy: 9
- Buy: 6
- Hold: 9
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the CVX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 170.1 | 9.7% |
| Analysts Target Price | 170.1 | 9.7% |
| ValueRay Target Price | 158.9 | 2.5% |
CVX Fundamental Data Overview November 01, 2025
P/E Trailing = 19.758
P/E Forward = 16.2338
P/S = 1.6343
P/B = 2.1105
P/EG = 2.4589
Beta = 0.813
Revenue TTM = 188.49b USD
EBIT TTM = 22.28b USD
EBITDA TTM = 41.71b USD
Long Term Debt = 19.59b USD (from longTermDebt, last fiscal year)
Short Term Debt = 4.41b USD (from shortTermDebt, last fiscal year)
Debt = 41.54b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 33.82b USD (from netDebt column, last quarter)
Enterprise Value = 309.32b USD (309.32b + Debt 41.54b - CCE 41.54b)
Interest Coverage Ratio = 21.12 (Ebit TTM 22.28b / Interest Expense TTM 1.05b)
FCF Yield = 3.39% (FCF TTM 10.49b / Enterprise Value 309.32b)
FCF Margin = 5.57% (FCF TTM 10.49b / Revenue TTM 188.49b)
Net Margin = 6.82% (Net Income TTM 12.85b / Revenue TTM 188.49b)
Gross Margin = 26.86% ((Revenue TTM 188.49b - Cost of Revenue TTM 137.87b) / Revenue TTM)
Gross Margin QoQ = 43.12% (prev 11.89%)
Tobins Q-Ratio = 0.95 (Enterprise Value 309.32b / Total Assets 326.50b)
Interest Expense / Debt = 0.89% (Interest Expense 370.0m / Debt 41.54b)
Taxrate = 33.27% (1.80b / 5.41b)
NOPAT = 14.87b (EBIT 22.28b * (1 - 33.27%))
Current Ratio = 1.08 (Total Current Assets 41.54b / Total Current Liabilities 38.56b)
Debt / Equity = 0.22 (Debt 41.54b / totalStockholderEquity, last quarter 189.84b)
Debt / EBITDA = 0.81 (Net Debt 33.82b / EBITDA 41.71b)
Debt / FCF = 3.22 (Net Debt 33.82b / FCF TTM 10.49b)
Total Stockholder Equity = 159.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.94% (Net Income 12.85b / Total Assets 326.50b)
RoE = 8.06% (Net Income TTM 12.85b / Total Stockholder Equity 159.46b)
RoCE = 12.45% (EBIT 22.28b / Capital Employed (Equity 159.46b + L.T.Debt 19.59b))
RoIC = 8.40% (NOPAT 14.87b / Invested Capital 177.02b)
WACC = 8.01% (E(309.32b)/V(350.86b) * Re(9.01%) + D(41.54b)/V(350.86b) * Rd(0.89%) * (1-Tc(0.33)))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.62%
[DCF Debug] Terminal Value 70.59% ; FCFE base≈13.91b ; Y1≈11.06b ; Y5≈7.43b
Fair Price DCF = 58.14 (DCF Value 117.14b / Shares Outstanding 2.01b; 5y FCF grow -24.45% → 3.0% )
EPS Correlation: -94.92 | EPS CAGR: -34.05% | SUE: 0.10 | # QB: 0
Revenue Correlation: -59.98 | Revenue CAGR: -4.41% | SUE: 0.22 | # QB: 0
Additional Sources for CVX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle